HUTCHMED
-
Ticker
HCM
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 1001-5000 Employees
- Based in Central, Hong Kong
HUTCHMED (Nasdaq/AIM:HCM; HKEX:13) is an innovative, commercial-stage, biopharmaceutical company. It is committed to the discovery and global development and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. A dedicated organization of over 1,300 personnel has advanced ten cancer drug candidates from in-house discovery into
…More clinical studies around the world, with its first three oncology drugs now approved and launched.
HUTCHMED
Most Recent Responsibility Report
MOST RECENT
2023 Sustainability Report
Archived Responsibility Reports
Our service enables potential investors to review the most recent and archived HUTCHMED Sustainability Report, HUTCHMED Corporate Social Responsibility Report, HUTCHMED CSR Report, HUTCHMED Corporate Responsibility, HUTCHMED CR Report, HUTCHMED Citizenship Report, HUTCHMED ESG Report, and HUTCHMED Environmental Report online.